Takeda Pharmaceutical Co Stock Volatility
TKPHF Stock | USD 25.12 0.67 2.74% |
Takeda Pharmaceutical owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0556, which indicates the firm had a -0.0556% return per unit of risk over the last 3 months. Takeda Pharmaceutical Co exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Takeda Pharmaceutical's Variance of 8.16, coefficient of variation of (2,588), and Risk Adjusted Performance of (0.02) to confirm the risk estimate we provide. Key indicators related to Takeda Pharmaceutical's volatility include:
180 Days Market Risk | Chance Of Distress | 180 Days Economic Sensitivity |
Takeda Pharmaceutical Pink Sheet volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Takeda daily returns, and it is calculated using variance and standard deviation. We also use Takeda's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Takeda Pharmaceutical volatility.
Takeda |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Takeda Pharmaceutical can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Takeda Pharmaceutical at lower prices to lower their average cost per share. Similarly, when the prices of Takeda Pharmaceutical's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving together with Takeda Pink Sheet
0.76 | MKKGY | Merck KGaA ADR | PairCorr |
0.77 | MKGAF | MERCK Kommanditgesells | PairCorr |
0.82 | TAK | Takeda Pharmaceutical | PairCorr |
Moving against Takeda Pink Sheet
0.76 | APAC | Stonebridge Acquisition Symbol Change | PairCorr |
0.73 | AAC | Ares Acquisition | PairCorr |
0.71 | TRCA | Twin Ridge Capital | PairCorr |
0.64 | ARTE | Artemis Strategic | PairCorr |
0.44 | INTE | Integral Acquisition | PairCorr |
0.4 | TEVA | Teva Pharma Industries | PairCorr |
Takeda Pharmaceutical Market Sensitivity And Downside Risk
Takeda Pharmaceutical's beta coefficient measures the volatility of Takeda pink sheet compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Takeda pink sheet's returns against your selected market. In other words, Takeda Pharmaceutical's beta of -0.24 provides an investor with an approximation of how much risk Takeda Pharmaceutical pink sheet can potentially add to one of your existing portfolios. Takeda Pharmaceutical Co exhibits very low volatility with skewness of -0.13 and kurtosis of 1.71. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Takeda Pharmaceutical's pink sheet risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Takeda Pharmaceutical's pink sheet price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Takeda Pharmaceutical Demand TrendCheck current 90 days Takeda Pharmaceutical correlation with market (Dow Jones Industrial)Takeda Beta |
Takeda standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 2.88 |
It is essential to understand the difference between upside risk (as represented by Takeda Pharmaceutical's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Takeda Pharmaceutical's daily returns or price. Since the actual investment returns on holding a position in takeda pink sheet tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Takeda Pharmaceutical.
Takeda Pharmaceutical Pink Sheet Volatility Analysis
Volatility refers to the frequency at which Takeda Pharmaceutical pink sheet price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Takeda Pharmaceutical's price changes. Investors will then calculate the volatility of Takeda Pharmaceutical's pink sheet to predict their future moves. A pink sheet that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A pink sheet with relatively stable price changes has low volatility. A highly volatile pink sheet is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Takeda Pharmaceutical's volatility:
Historical Volatility
This type of pink sheet volatility measures Takeda Pharmaceutical's fluctuations based on previous trends. It's commonly used to predict Takeda Pharmaceutical's future behavior based on its past. However, it cannot conclusively determine the future direction of the pink sheet.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Takeda Pharmaceutical's current market price. This means that the pink sheet will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Takeda Pharmaceutical's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Takeda Pharmaceutical Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Takeda Pharmaceutical Projected Return Density Against Market
Assuming the 90 days horizon Takeda Pharmaceutical Co has a beta of -0.2422 . This usually implies as returns on the benchmark increase, returns on holding Takeda Pharmaceutical are expected to decrease at a much lower rate. During a bear market, however, Takeda Pharmaceutical Co is likely to outperform the market.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Takeda Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Takeda Pharmaceutical's price will be affected by overall pink sheet market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Takeda pink sheet's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Takeda Pharmaceutical Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
Returns |
What Drives a Takeda Pharmaceutical Price Volatility?
Several factors can influence a pink sheet's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Takeda Pharmaceutical Pink Sheet Risk Measures
Assuming the 90 days horizon the coefficient of variation of Takeda Pharmaceutical is -1798.9. The daily returns are distributed with a variance of 8.32 and standard deviation of 2.88. The mean deviation of Takeda Pharmaceutical Co is currently at 1.72. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.8
α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | -0.24 | |
σ | Overall volatility | 2.88 | |
Ir | Information ratio | -0.05 |
Takeda Pharmaceutical Pink Sheet Return Volatility
Takeda Pharmaceutical historical daily return volatility represents how much of Takeda Pharmaceutical pink sheet's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company shows 2.8837% volatility of returns over 90 . By contrast, Dow Jones Industrial accepts 0.8025% volatility on return distribution over the 90 days horizon. Performance |
Timeline |
About Takeda Pharmaceutical Volatility
Volatility is a rate at which the price of Takeda Pharmaceutical or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Takeda Pharmaceutical may increase or decrease. In other words, similar to Takeda's beta indicator, it measures the risk of Takeda Pharmaceutical and helps estimate the fluctuations that may happen in a short period of time. So if prices of Takeda Pharmaceutical fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan. Takeda Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 47347 people.
Takeda Pharmaceutical's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Takeda Pink Sheet over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Takeda Pharmaceutical's price varies over time.
3 ways to utilize Takeda Pharmaceutical's volatility to invest better
Higher Takeda Pharmaceutical's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Takeda Pharmaceutical stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Takeda Pharmaceutical stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Takeda Pharmaceutical investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Takeda Pharmaceutical's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Takeda Pharmaceutical's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Takeda Pharmaceutical Investment Opportunity
Takeda Pharmaceutical Co has a volatility of 2.88 and is 3.6 times more volatile than Dow Jones Industrial. Compared to the overall equity markets, volatility of historical daily returns of Takeda Pharmaceutical Co is lower than 25 percent of all global equities and portfolios over the last 90 days. You can use Takeda Pharmaceutical Co to enhance the returns of your portfolios. The pink sheet experiences an expected bullish sentiment for its category. Check odds of Takeda Pharmaceutical to be traded at $30.14 in 90 days.Good diversification
The correlation between Takeda Pharmaceutical Co and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and DJI in the same portfolio, assuming nothing else is changed.
Takeda Pharmaceutical Additional Risk Indicators
The analysis of Takeda Pharmaceutical's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Takeda Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some common measures of Takeda Pharmaceutical pink sheet's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Risk Adjusted Performance | (0.02) | |||
Market Risk Adjusted Performance | 0.507 | |||
Mean Deviation | 1.69 | |||
Coefficient Of Variation | (2,588) | |||
Standard Deviation | 2.86 | |||
Variance | 8.16 | |||
Information Ratio | (0.05) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential pink sheets, we recommend comparing similar pink sheets with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Takeda Pharmaceutical Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Takeda Pharmaceutical as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Takeda Pharmaceutical's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Takeda Pharmaceutical's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Takeda Pharmaceutical Co.
Complementary Tools for Takeda Pink Sheet analysis
When running Takeda Pharmaceutical's price analysis, check to measure Takeda Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Takeda Pharmaceutical is operating at the current time. Most of Takeda Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Takeda Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Takeda Pharmaceutical's price. Additionally, you may evaluate how the addition of Takeda Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Transaction History View history of all your transactions and understand their impact on performance | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data |